539561-BOM

Supha Pharmachem Ltd.

BSE: 539561

Sector: Services

Industry Group: Commercial Services & Supplies

Industry: Trading & Distributors

0.35+0.0 (+2.94%)

24 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

30.87

P/E (TTM)

2.57

P/B

0.29

P/S (TTM)

0.06

EV/EBITDA

337.92

CAPE (5Y)

1.38

ROE (TTM)

15.87

ROCE (TTM)

0.46

ROA (TTM)

0.64

Avg 3Y ROE

66.20

Earnings 3Y CAGR

-4.36

Sales 3Y CAGR

1.48

Sales 5Y CAGR

Debt/Equity

10.34

Consensus TP

Strong Buy %

Promoter Holding

Pledged %

Stock Analysis

Fundamental analysis overview of Supha Pharmachem Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is cheap and PE TTM is at a discount to industry median

PE TTM of 2.57 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -88.95%

What is P/E Ratio?

Median: 23.25

Value 2.57

-379.032237.53

Negative

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Supha Pharmachem Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Supha Pharmachem Ltd. Shareholding Pattern

Quarterly breakdown of Supha Pharmachem Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Promoter	43.57	43.57	43.57	43.57	34.96	8.43	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.13	1.13	1.13
Indian Promoter	43.57	43.57	43.57	43.57	34.96	8.43	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.13	1.13	1.13
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.04	0.08	0.04	0.04	0.00	0.00	0.00	0.00	0.00	0.00	1.70
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.04	0.08	0.04	0.04	0.00	0.00	0.00	0.00	0.00	0.00	1.70
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	56.43	56.43	56.43	56.43	65.04	91.57	98.89	98.89	98.89	98.89	98.89	98.89	98.89	98.85	98.81	98.85	98.85	98.89	98.89	98.89	98.89	98.87	98.87	97.17
Bodies Corporate	0.00	0.00	-	-	-	0.17	-	0.68	0.90	0.02	7.63	7.63	7.67	7.87	8.74	9.51	9.90	7.38	3.71	2.46	1.29	8.49	7.81	6.23
Others (incl. Retail) No. of shareholders	56.43 250	56.43 252	56.43 378	56.43 408	65.04 444	91.40 838	98.89 839	98.21 706	97.99 651	98.87 617	91.26 599	91.26 616	91.22 699	90.98 1,712	90.07 3,954	89.34 3,829	88.95 15,527	91.51 26,393	95.18 67,315	96.43 73,548	97.60 1,10,347	90.38 1,13,458	91.06 1,14,039	90.94 1,11,192

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Supha Pharmachem Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
Prakash Anand Gupta	17 Jun 2026	sell	₹ 0.27	65.10 lac	-
Rg Traders	07 Apr 2026	sell	₹ 0.34	44.56 lac	-
Rg Traders	30 Mar 2026	buy	₹ 0.32	74.02 lac	-
Aakashhiteshbhaizinzuvadia	30 Mar 2026	sell	₹ 0.32	56.85 lac	-
L7 Hitech Private Limited	18 Mar 2026	sell	₹ 0.39	76.38 lac	-
Jasmitsinghchandhok	12 Mar 2026	buy	₹ 0.47	72.00 lac	-
Ishaan Tradefin Llp	12 Mar 2026	buy	₹ 0.45	9.39 lac	-
Ishaan Tradefin Llp	12 Mar 2026	sell	₹ 0.46	59.39 lac	-
Share India Securities Limited	12 Mar 2026	buy	₹ 0.47	93.67 lac	-
Share India Securities Limited	12 Mar 2026	sell	₹ 0.46	90.64 lac	-

…

Corporate Actions

History of Supha Pharmachem Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Rights Issue(61 new shares @ ₹1 for 50 existing shares)
Ex-date: 15th Apr 2025Announced on: 7th Apr 2025
"Rights ISIN INE549S20010SEDOL BT8TFK6."
Bonus3 new shares for 1 existing shares
Ex-date: 5th Jul 2024Announced on: 27th May 2024
Stock Split1 : 5
Ex-date: 23rd Feb 2024Announced on: 8th Jan 2024
Nominal value change from INR 5 to INR 1.
Stock Split1 : 2
Ex-date: 1st Sep 2023Announced on: 23rd Jun 2023
Nominal value change from INR 10 to INR 5.
Bonus9 new shares for 5 existing shares
Ex-date: 28th Jul 2023Announced on: 23rd Jun 2023

Company Profile

Overview of Supha Pharmachem Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Supha Pharmachem Limited, formerly Remedium Lifecare Limited, is an India-based pharmaceutical and specialty chemicals company engaged in trading and distribution of raw materials for the pharmaceutical industry. The Company is engaged in the business of trading in advanced pharmaceutical intermedia...

Key personnel

Mr. Bikram Kumar Mund

Additional Non-Executive Independent Director

Mr. Ashish Dinanath Parkar

Chief Financial Officer

Mr. Adarsh Deepak MunjalD

Whole Time Director

Mr. Vignesh Laxman GawdeD

Non-Executive Non-Independent Director

Mr. Rambhajan VishwakarmaD

Non-Executive Non-Independent Director

Ms. Shamim Adil MichalD

Additional Independent Director

Mr. Vijay Pal Singh GulyaD

Additional Non-Executive Independent Director

Mr. Bikram Kumar MundD

Additional Non-Executive Independent Director

View all

Incorporated on

19 Feb 1988

Last Annual

31 Mar 2025

Last Interim

30 Sep 2025

No. of Employees

IPO date

12 Jan 2016

Free Float

70,43,14,293

Website

https://www.remlife.com/

Phone no.

+912228505005

Address

Office No.9, K Raheja Prime,, Marol Industrial Estate, Andheri East, MUMBAI, 400059, India

Frequently Asked Questions

What is the current share price of Supha Pharmachem Ltd.?

The current share price of Supha Pharmachem Ltd. is ₹ 0.35 as of 24 Jul 2026.

What is the market capitalisation of Supha Pharmachem Ltd.?

The market capitalisation of Supha Pharmachem Ltd. stands at ₹ 30.87 Cr.

What is the PE ratio of Supha Pharmachem Ltd.?

The Price-to-Earnings (PE) ratio of Supha Pharmachem Ltd. is 2.57 as of the latest trailing twelve months data.

What is the ROE and ROCE of Supha Pharmachem Ltd.?

Supha Pharmachem Ltd. has a Return on Equity (ROE) of 15.87% and a Return on Capital Employed (ROCE) of 0.46% as per the latest financial reports.

What is the 52-week high and low of Supha Pharmachem Ltd.?

The 52-week high of Supha Pharmachem Ltd. is - and the 52-week low is -.

What is the dividend yield of Supha Pharmachem Ltd.?

The dividend yield of Supha Pharmachem Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Supha Pharmachem Ltd.?

Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of Supha Pharmachem Ltd. shares.

What sector does Supha Pharmachem Ltd. belong to?

Supha Pharmachem Ltd. operates in the Services sector.

What is the beta of Supha Pharmachem Ltd.?

The beta of Supha Pharmachem Ltd. is 0.36, indicating its price volatility relative to the broader market.

What is the RSI of Supha Pharmachem Ltd.?

The 14-day Relative Strength Index (RSI) of Supha Pharmachem Ltd. is 61.67, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Supha Pharmachem Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Supha Pharmachem Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Company Profile

Stock Analysis

Corporate Actions